Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multi-center, Phase 1b/2a Basket Trial of IDX-1197 in Patients With Homologous Recombination Repair Mutated Solid Tumors

NCT04174716 is registered in ClinicalTrials.gov with Idience Co., Ltd. as lead sponsor.

NCT NCT04174716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04174716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multi-center, Phase 1b/2a Basket Trial of IDX-1197 in Patients With Homologous Recombination Repair Mutated Solid Tumors
Lead sponsor
Idience Co., Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
November 6, 2019
Completion date
June 28, 2024
Enrollment
108 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

homologous recombination deficiency, homologous recombination repair gene mutation, solid tumors